Juan Manuel García‐Martínez

Author

Also Known As

J M García-Martínez, J.M. García-Martínez, Juan M García-Martínez, Juan M. Garcia-Martinez, Juan M. García-Martínez, Juan M. García‐Martínez, Juan Manuel Garcia-Martinez, Juan Manuel García-Martínez, Juan Manuel García‐Martínez, Juan M. García-Martínez

Publications

Citations

H-Index

Concepts

All Affiliations

Universitat de Barcelona Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Biomedical Research Networking Center on Neurodegenerative Diseases MRC Protein Phosphorylation and Ubiquitylation Unit University of Dundee

About

Juan Manuel García‐Martínez is an author at Universitat de Barcelona specializing in medicine, neuroscience, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.4K
2	Natural Sciences	2	2	920
3	Biochemistry	2	2	920
4	Health Sciences	1	1	127
5	Social Sciences	1	1	11

Juan Manuel García‐Martínez

Publications

Citations

H-Index

Page 1

	Year	Citations
mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1) Juan Manuel García‐Martínez, Dario R. Alessi Biochemical Journal Molecular RegulationMtorc1 ActivityCellular PhysiologySignaling PathwayCell Regulation	2008	881
Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR) Juan Manuel García‐Martínez, Jennifer L. Moran, Rosemary G. Clarke, Biochemical Journal	2009	460
New Insights into mTOR Signaling: mTORC2 and Beyond Dario R. Alessi, Laura R. Pearce, Juan Manuel García‐Martínez Science Signaling Molecular PhysiologySignal TransductionCell RegulationMolecular RegulationMedicine	2009	186
Mutation of the PDK1 PH Domain Inhibits Protein Kinase B/Akt, Leading to Small Size and Insulin Resistance José R. Bayascas, Stephan Wullschleger, Kei Sakamoto, Molecular and Cellular Biology Ribosomal S6 KinaseMolecular BiologyInsulin SignalingMetabolic SyndromeSignaling Pathway	2008	127
PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum Ana Saavedra, Juan Manuel García‐Martínez, Xavier Xifró, Cell Death and Differentiation Neurodegenerative DiseasesMolecular NeuroscienceMolecular PhysiologyLeucine-rich Repeat ProteinDisease Striatum	2009	61
Calcineurin is involved in the early activation of NMDA‐mediated cell death in mutant huntingtin knock‐in striatal cells Xavier Xifró, Juan Manuel García‐Martínez, Daniel del Toro, Journal of Neurochemistry	2008	54
Effect of PI3K- and mTOR-specific inhibitors on spontaneous B-cell follicular lymphomas in PTEN/LKB1-deficient mice Juan Manuel García‐Martínez, Stephan Wullschleger, G Preston, British Journal of Cancer	2011	48
Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodeling of both postsynaptic density and NMDA receptor signaling Jesús F. Torres-Peraza, Albert Giralt, Juan Manuel García‐Martínez, Neurobiology of Disease Synaptic PlasticityStriatal Glutamatergic TransmissionSynaptic TransmissionNeurotransmitterMolecular Biology	2007	46
Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: Role in excitotoxicity Xavier Xifró, Albert Giralt, Ana Saavedra, Neurobiology of Disease Exon-1 Mouse ModelsBiochemistryNatural SciencesMolecular BiologyNeurochemical Biomarkers	2009	39
Selective Tumor Cell Apoptosis and Tumor Regression in CDH17-Positive Colorectal Cancer Models using BI 905711, a Novel Liver-Sparing TRAILR2 Agonist Juan Manuel García‐Martínez, Shirley Wang, Cordula Weishaeupl, Molecular Cancer Therapeutics	2020	39

Page 1